STOCK TITAN

newcleo controller reports 4,920 ordinary shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

newcleo plc (NWCL) reports Group Controller Matthieu Houmeau’s direct holdings: 4,920 Ordinary Shares and 492 Class B Shares as of November 9, 2026. Direct options to buy Ordinary Shares have an exercise price of $0.0228 and are listed with expiration dates from August 31, 2033, through December 1, 2035. Company Earnout Bonus Options have price-based and service vesting conditions; the Class B Shares are subject to automatic one-for-one conversion under stated price conditions.

Insider Houmeau Matthieu
Role Group Controller
Type Security Shares Price Value
Holding Stock Options (Right to Buy) F1 -- -- --
Holding Stock Options (Right to Buy) F2 -- -- --
Holding Stock Options (Right to Buy) F3 -- -- --
Holding Stock Options (Right to Buy) F4 -- -- --
Holding Stock Options (Right to Buy) F5, F6 -- -- --
Holding Stock Options (Right to Buy) F5, F7 -- -- --
Holding Stock Options (Right to Buy) F5, F8 -- -- --
Holding Stock Options (Right to Buy) F5, F9 -- -- --
Holding Class B Shares F10 -- -- --
Holding Ordinary Shares -- -- --
Holdings: Stock Options (Right to Buy) — 95,057 options (Direct); Class B Shares — 492 shares (Direct); Ordinary Shares — 4,920 shares (Direct)
Footnotes (10)
  1. F1. Represents stock options granted on September 1, 2023 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
  2. F2. Represents stock options granted on September 1, 2024 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
  3. F3. Represents stock options granted on June 1, 2025 that were fully vested upon grant.
  4. F4. Represents stock options granted on December 1, 2025 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
  5. F5. Represents the grant on September 21, 2026 of "Company Earnout Bonus Options" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the "BCA"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
  6. F6. These stock options vest as to service on each of the first four anniversaries of September 1, 2023, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
  7. F7. These stock options vest as to service on each of the first four anniversaries of September 1, 2024, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
  8. F8. These stock options were fully vested as to service as of the grant date.
  9. F9. These stock options vest as to service on each of the first four anniversaries of December 1, 2025, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
  10. F10. Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary Shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided, in each case, that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Ordinary Shares held directly 4,920 shares Reported November 9, 2026
Class B Shares held directly 492 shares Reported November 9, 2026
Options underlying shares 1,941 shares September 1, 2023 grant; expiration August 31, 2033; exercise price $0.0228 per share
Options underlying shares 8,938 shares September 1, 2024 grant; expiration August 31, 2034; exercise price $0.0228 per share
Options underlying shares 3,433 shares June 1, 2025 grant; expiration May 31, 2035; exercise price $0.0228 per share
Options underlying shares 72,105 shares December 1, 2025 grant; expiration December 1, 2035; exercise price $0.0228 per share
Option exercise price $0.0228 per share Direct options to buy Ordinary Shares
Company Earnout Bonus Options technical
"grant of Company Earnout Bonus Options to purchase Ordinary Shares"
time-based vesting technical
"subject to time-based vesting"
Time-based vesting is a schedule that gives employees or contractors ownership of granted stock or options gradually as they remain with a company, like unlocking rewards in a loyalty program the longer you stick around. For investors, it matters because it affects future share supply, management incentives and staff retention — all of which can influence company performance and dilution of existing shareholders.
volume-weighted average price financial
"volume-weighted average price per Ordinary Share"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
service vesting conditions technical
"satisfy applicable service vesting conditions"
accelerated vesting provisions technical
"applicable accelerated vesting provisions"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Matthieu Houmeau hold directly in NWCL?

The report lists 4,920 Ordinary Shares and 492 Class B Shares as direct holdings as of November 9, 2026.

What is the exercise price and expiration range of Matthieu Houmeau’s NWCL options?

The listed options have an exercise price of $0.0228 per Ordinary Share. Their expiration dates range from August 31, 2033, through December 1, 2035.

What are the vesting conditions for Houmeau’s NWCL Company Earnout Bonus Options?

Half vest at the $15.00 price test and half at the $18.00 price test. The first half requires the volume-weighted average price per Ordinary Share to meet or exceed $15.00 during any 20 trading days within a 30 trading day period; the second requires it to meet or exceed $18.00 during any trading days within a 30 trading day period. The tests must occur between September 21, 2026 and September 21, 2031, and service vesting conditions apply.

How do Houmeau’s NWCL Class B Shares convert?

The Class B Shares automatically convert one-for-one into Ordinary Shares in two 50% portions if the stated price tests are met: the $15.00 test over any 20 trading days within a 30 trading day period, and the $18.00 test during any trading days within a 30 trading day period. The tests must occur from September 21, 2026 through the five-year anniversary of that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Houmeau Matthieu

(Last)(First)(Middle)
55 SOUTH AUDLEY STREET

(Street)
LONDONW1K 2QH

(City)(State)(Zip)

UNITED KINGDOM

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
11/09/2026
3. Issuer Name and Ticker or Trading Symbol
newcleo plc [ NWCL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Group Controller
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares4,920D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy) (1)08/31/2033Ordinary Shares1,941$0.0228D
Stock Options (Right to Buy) (2)08/31/2034Ordinary Shares8,938$0.0228D
Stock Options (Right to Buy) (3)05/31/2035Ordinary Shares3,433$0.0228D
Stock Options (Right to Buy) (4)12/01/2035Ordinary Shares72,105$0.0228D
Stock Options (Right to Buy)(5) (5)(6)08/31/2033Ordinary Shares194(5)(6)$0.0228D
Stock Options (Right to Buy)(5) (5)(7)08/31/2034Ordinary Shares893(5)(7)$0.0228D
Stock Options (Right to Buy)(5) (5)(8)05/31/2035Ordinary Shares343(5)(8)$0.0228D
Stock Options (Right to Buy)(5) (5)(9)12/01/2035Ordinary Shares7,210(5)(9)$0.0228D
Class B Shares (10) (10)Ordinary Shares492(10)(10)D
Explanation of Responses:
1. Represents stock options granted on September 1, 2023 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
2. Represents stock options granted on September 1, 2024 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
3. Represents stock options granted on June 1, 2025 that were fully vested upon grant.
4. Represents stock options granted on December 1, 2025 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
5. Represents the grant on September 21, 2026 of "Company Earnout Bonus Options" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the "BCA"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions.
6. These stock options vest as to service on each of the first four anniversaries of September 1, 2023, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
7. These stock options vest as to service on each of the first four anniversaries of September 1, 2024, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
8. These stock options were fully vested as to service as of the grant date.
9. These stock options vest as to service on each of the first four anniversaries of December 1, 2025, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
10. Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary Shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided, in each case, that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kateryna Fedorova, attorney-in-fact for Matthieu Houmeau11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading